How Is MGUS Monitored?

Myeloma expert Dr. Irene Ghobrial discusses how patients with monoclonal gammopathy of undetermined significance (MGUS) are monitored over time and shares an update on research being conducted to learn more about this myeloma precursor condition.
Dr. Irene Ghobrial is Director of the Clinical Investigator Research Program at Dana-Farber Cancer Institute and Professor of Medicine at Harvard Medical School. Learn more about Dr. Ghobrial, here:
www.dana-farbe....
Patient Empowerment Network (PEN) is a 501(c)(3) non-profit organization. PEN’s mission is to fortify cancer patients and care partners with the knowledge and tools to boost their confidence, put them in control of their healthcare journey, and assist them in receiving the best, most personalized care available to ensure they have the best possible outcome. Subscribe now to receive the latest news on cancer treatment and research: powerfulpatien...

[@thomasfraser9072]

I am positive for MGUS the precursor for MM and have taken on my own Quercetin 500 mg a day for 3 years now as a chemo preventative treatment to MM. I read research papers that support this as does my oncologist. And at age 76 so far so good.
I was in Vietnam and Camp Lejeune. So My VA oncologist will monitor my blood and urine every 6 months. So I am lucky for that.

[@buddhadharma1683]

What are treatment modalities for prevention and behavioral modification mentioned in this video?